Oncotelic Therapeutics: Entry Into A Material Definitive Agreement, The Company Fully Repaid The May 2021 And June 2021 Geneva Notes Of $203,750 $103,750, Respectively, Including Interest And Prepayment Penalty In Full, And In Compliance With The Prior Issuances, Creation Of A Direct Financial Obligation Or An Obligation Under An Off-balance Sheet Arrangement Of A Registrant, Unregistered Sale Of Equity Securities, Financial Statements And Exhibits
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameOncotelic Therapeutics Inc
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









